Brad Rovin

Director, Division of Nephrology Vice Chair of Research, Internal Medicine Professor of Internal Medicine and Pathology · Ohio State University Hospital

Credentials: · · · · · ·

History

Department of Internal Medicine · Washington University/B-JH/SLCH Consortium
Present
Ohio State University Hospital
Present
Ohio State University Hospital
Present

Nephrology
Washington University/B-JH/SLCH Consortium
1989–1991
Barnes-Jewish Hospital
1986–1989
Internal Medicine
University of Virginia Medical Center
1983–1986
Washington University School of Medicine
1979–1983
Northwestern University

Research

Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study
Arthritis & Rheumatism · 2012 · First of 12 authors · Corresponding · 1,098 citations
The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility
Science · 2005 · 860 citations
Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis
New England Journal of Medicine · 2020 · 775 citations

LH
Lee Hebert
78 papers
Samir Parikh
54 papers · 9 as a fellow
Tibor Nadasdy
43 papers
Anjali Satoskar
41 papers
Sergey Brodsky
36 papers
Jonathan Barratt
32 papers · 24 as a resident
Isabelle Ayoub
29 papers
Richard Lafayette
22 papers
Richard Furie
19 papers
Jai Radhakrishnan
18 papers
Maria Dall'Era
18 papers
SA
Salem Almaani
17 papers · 4 as a fellow

Grants

Muscle-Kidney Crosstalk in Age-Related Kidney Disease
National Institute on Aging · R01
PI · $2.3M · Ohio State University
2020–2027
Lupus Omics Cutaneous Kidney Investigative Team (LOCKIT)
National Institute of Arthritis and Musculoskeletal and Skin Diseases · UC2
PI · $6.3M · New York University School of Medicine
2022–2026
Targeting Aberrant Expression of Cytokines/Chemokines for an Inflammatory Nephritis Cure
National Institute of Allergy and Infectious Diseases · R21
PI · $433.1K · Ohio State University
2022–2026
Predictive Biomarkers for Disease Activity and Organ Damage in Patients with Lupus
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R01
PI · $3.2M · Medical University of South Carolina
2018–2024

Clinical trials

ACTHAR GEL in Patients With Membranous (Class V) Lupus Nephritis
Principal investigator · Withdrawn · Phase 4
Ohio State University
2013–2018
Per-protocol Repeat Kidney Biopsy in Incident Cases of Lupus Nephritis
Study chair · Recruiting
Karolinska Institutet
2022–2028